KATHERINE MURPHY: Open Payments
NPI 1881245876 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,375 in 114 payments from 18 companies in 2025. Trend: 2023 $1,721 · 2024 $2,091 · 2025 $2,375
Food & beverage: $2,375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $386 |
| Regeneron Healthcare Solutions, Inc. | 11 | $286 |
| Lilly USA, LLC | 11 | $285 |
| GENZYME CORPORATION | 9 | $207 |
| PFIZER INC. | 9 | $173 |
| Incyte Corporation | 7 | $165 |
| Arcutis Biotherapeutics, Inc. | 8 | $147 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Amgen Inc. | 5 | $104 |
| Janssen Biotech, Inc. | 4 | $88 |
Products named: DUPIXENT, RINVOQ, EBGLYSS, CIBINQO, OPZELURA, Zoryve, SKYRIZI, Otezla.
Industry payments across NY — which companies pay providers there.
